Deacetylcedilan glucosyl modified compound liposome and its application

A deacetylcedilan, glucose-based technology, applied in the directions of steroids, drug combinations, organic chemistry, etc., can solve the problems of shortened maintenance time, reduced anticancer activity titer, high risk of anticancer application, etc. Enhanced inhibition rate, reduced arrhythmia, prolonged anti-cancer effect

Active Publication Date: 2021-05-14
GUILIN MEDICAL UNIVERSITY
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, deacetyl cedilan (cedilan) can lose glucose and acetic acid through hydrolysis in the body, and form digoxin with almost no anti-hepatic effect, which reduces the anticancer activity of deacetyl cedilan and maintains its effect. shortening of time
In addition, due to the prevalent cardiotoxicity of cardiac glycosides, their anticancer application is risky

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Deacetylcedilan glucosyl modified compound liposome and its application
  • Deacetylcedilan glucosyl modified compound liposome and its application
  • Deacetylcedilan glucosyl modified compound liposome and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0036] The anti-cancer experiments of the above drugs in vivo and in vitro are carried out by establishing in vitro cell culture and in vivo animal models. The experimental method includes the following steps:

[0037] ① Carry out the culture of cancer cells and normal cells;

[0038] ②Comparison of deacetylated cedilan glucosyl-modified compound and cedilan in vitro anti-cancer and toxicity to normal cells;

[0039] ③Establish a nude mouse animal model of liver cancer, and carry out in vivo anti-cancer comparative experiments between deacetylated cedilan glucosyl-modified compound liposomes and cedilan liposomes;

[0040] ④Evaluation of acetylated cedilan glucosyl-modified compound liposome and cedilan cardiotoxicity.

[0041] 1. In vitro anticancer experiment

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a deacetylcedilan glucosyl modified compound liposome and application thereof. It is mainly modified from the glucosyl group of cedilan, using glucose and 2-glucosamine as raw materials for partial modification of the molecule, and then connecting with the terminal 3-hydroxyl of digoxin to generate a glucosyl-modified product of deacetyl cedilan. Select the desired molecule under the activity guide. By synthesizing deacetylated cedilan glucosyl-modified compounds (2‑O‑benzyl‑β‑D‑glucopyranoside‑deacetyl cedilan, etc.), to strengthen the anticancer effects of these compounds and improve efficacy Increase the potency and prolong the half-life. At the same time, the modified compound is prepared into liposomes to improve its liver targeting effect and reduce cardiotoxicity.

Description

technical field [0001] The invention relates to a modified compound, in particular to a new compound obtained by chemically modifying the traditional drug deacetylcedilan for the treatment of heart failure, and its application in anti-cancer after modification of liposome dosage form, namely deacetylcedilan chemical Modified into deacetylcedilan glucosyl modified compound (2-O-benzyl-β-D-glucopyranoside-deacetylcedilan) and prepared into liver targeting liposomes in anti-liver cancer drugs Applications. Background technique [0002] Among the common cancers in the world, the incidence of liver cancer ranks seventh, and the incidence of cases in China exceeds 50% of the global total, despite the adoption of treatment methods including tumor resection, liver transplantation, sorafenib and local therapy (radiofrequency ablation) However, the mortality rate of liver cancer has not decreased yet. Therefore, the development of high-efficiency and low-toxicity anti-liver cancer dr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07J63/00A61K31/56A61P35/00A61P1/16A61K9/50A61K9/10A61K47/36
Inventor 谭宁徐庆潘光玉秦永俊陈果
Owner GUILIN MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap